Stay updated on ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer

Sign up to get notified when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.
Latest website image capture
Clouds background image

Latest updates to the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page

  1. Check
    7 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T11:21:07.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A site-wide banner announces an NIH transition in terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T12:06:28.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T12:38:42.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T13:57:48.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, blocking access to the study record. The header and footer remain visible, but the actual study details cannot be retrieved.
    Difference
    18%
    Check dated 2026-09-19T17:55:52.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    A note about a 2017 NIH grant/contract was added, and the site revision was updated to v3.6.6, replacing v3.6.5.
    Difference
    0.0%
    Check dated 2026-08-29T13:25:43.000Z thumbnail image

Stay in the know with updates to ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer

Enter your email address, and we'll notify you when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.